2 news items
Evoke Pharma Announces Closing of $7.5 Million Public Offering
EVOK
14 Feb 24
capital and general corporate purposes. Evoke may also use a portion of the net proceeds, together with its existing cash and cash equivalents
Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million
EVOK
9 Feb 24
the net proceeds from the public offering for working capital and general corporate purposes. Evoke may also use a portion of the net proceeds, together
- Prev
- 1
- Next